Rochester HIV vaccine, cure, and treatment trials center
University of Rochester HIV/AIDS Clinical Trials Unit
['FUNDING_OTHER'] · UNIVERSITY OF ROCHESTER · NIH-11231710
This program runs clinical trials of HIV vaccines, cure strategies, and treatments for people living with or at risk for HIV.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ROCHESTER (nih funded) |
| Locations | 1 site (ROCHESTER, UNITED STATES) |
| Trial ID | NIH-11231710 on ClinicalTrials.gov |
What this research studies
If you join one of the trials run through this University of Rochester unit, you would take part in visits, testing, and possible long-term follow-up at local clinic sites. The unit works within national HIV research networks (ACTG and HVTN) and coordinates studies testing vaccines, new therapies, and cure-related approaches. Staff emphasize community engagement, quality oversight, and clear communication about risks and benefits. The unit also supports laboratory testing and data collection to help researchers learn from each participant's experience.
Who could benefit from this research
Good fit: Ideal candidates include people living with HIV, people at higher risk of acquiring HIV, or healthy volunteers who meet specific trial eligibility and can attend Rochester-area sites.
Not a fit: People who cannot travel to the University of Rochester sites or who do not meet the specific inclusion criteria for individual trials are unlikely to benefit directly from participation.
Why it matters
Potential benefit: If successful, these trials could lead to better HIV prevention tools, improved treatments with fewer side effects, and progress toward a cure.
How similar studies have performed: Antiretroviral therapy and many ACTG/HVTN studies have produced major treatment and prevention advances, but broadly protective vaccines and a definitive cure remain unproven.
Where this research is happening
ROCHESTER, UNITED STATES
- UNIVERSITY OF ROCHESTER — ROCHESTER, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KEEFER, MICHAEL C — UNIVERSITY OF ROCHESTER
- Study coordinator: KEEFER, MICHAEL C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus